Ziconotide for spinal cord injury related pain
ConclusionThis study shows response to intrathecal ziconotide test in 40% of the patients of a very specific population in whom other therapeutic options are not available. This data justifies the development further studies such as a long term randomized controlled trial.This article is protected by copyright. All rights reserved.
Source: European Journal of Pain - Category: Anesthesiology Authors: Andrei Brinzeu,
Julien Berthiller,
Jean ‐Bernard Caillet,
Helene Staquet,
Patrick Mertens Tags: ORIGINAL ARTICLE Source Type: research
More News: Anesthesiology | Back Pain | Brain | Chronic Pain | Lumbar Puncture | Neurology | Pain | Pain Management | Spinal Cord Injury | Study